Gregg H Alton Novavax Inc (NVAX) insider trading activity

Gregg H Alton is Director of NOVAVAX INC. Currently has a direct ownership of 28,805 shares of NVAX, which is worth approximately $202,787. The most recent transaction as insider was on Jun 12, 2025, when has been sold 10,420 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.8K

56.68% 3M change

90.86% 12M change

Total Value Held $202,787

Gregg H Alton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2025	BUY Exercise of conversion of derivative security	-	10,420 Added 26.56%	28,805 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	$17,065 $8.61 p/Share	1,982 Added 9.73%	18,385 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	$16,741 $12.77 p/Share	1,311 Added 7.4%	16,403 Common Stock
Jun 30 2024	BUY Grant, award, or other acquisition	$16,743 $13.93 p/Share	1,202 Added 7.38%	15,092 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	-	6,670 Added 38.91%	10,470 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	$16,758 $4.9 p/Share	3,420 Added 32.14%	7,220 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	3,100 Added 44.93%	3,800 Common Stock
Jun 17 2022	BUY Exercise of conversion of derivative security	-	700 Added 50.0%	700 Common Stock

Also insider at

CORT

CORCEPT THERAPEUTICS INC Healthcare

ENOB

Enochian Biosciences Inc Healthcare

Director

GHA

Gregg H Alton

Director

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Value

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NOVAVAX INC

Track Activities on NVAX

Account